Combination trastuzumab and chemotherapy may have a role in women with small, node-negative, human epidermal growth factor receptor 2-positive breast cancer Journal Article

  

Authors:	Mcarthur, H. L.; Morris, P. G.; Hudis, C. A.
Article Title:	Combination trastuzumab and chemotherapy may have a role in women with small, node-negative, human epidermal growth factor receptor 2-positive breast cancer
Keywords:	cancer recurrence; cancer combination chemotherapy; drug efficacy; drug safety; systemic therapy; cancer adjuvant therapy; cancer patient; follow up; antineoplastic agent; letter; phenotype; breast cancer; epidermal growth factor receptor 2; distant metastasis; prescription; trastuzumab; risk management; recurrence free survival; randomized controlled trial (topic); phase 3 clinical trial (topic); lymph vessel metastasis; human; female; epidermal growth factor receptor 2 positive breast cancer
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	1
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-01-01
Start Page:	124
End Page:	125
Language:	English
DOI:	10.1200/jco.2014.58.2965
PROVIDER:	scopus
PUBMED:	25403210
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84920623976&partnerID=40&md5=c44c3cee333d0a757818c2be9ba25e93
Notes:	Export Date: 2 February 2015 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/67210